FDA Will Hold Public Hearing May 31 On CBD
The Food and Drug Administration will hold a public hearing May 31 regarding products containing cannabis or cannabis-derived compounds, like CBD, The National Law Review reports. The agenda for the hearing and a webcast are publicly available. The FDA would like comments by July 2 about any health or safety risks and information about production and marketing regarding CBD, which can be posted here.